BioScript Sustainability Report 2025 - EN

2025

SUSTAINABILITY REPORT

TABLE OF CONTENTS

04 SOCIAL 19 Patient Impact 20 Our Team Members & Well-Being 22 Indigenous Reconciliation & Equity

01

in Healthcare

INTRODUCTION Responsible Care for People and the Planet

5

Land Acknowledgement

5

A Message from our Co-Founders

6

About BioScript Solutions

7

22 Diversity, Inclusion, Belonging & Equity (DIBE)

23 Engagement, Listening & Culture 23 Learning, Development & Talent Retention

03

24 Community Engagement & Social Impact

ENVIRONMENTAL 14 14 15 16 17 17

Our Environmental Approach Science-Based Targets Climate Action & Carbon Management Data Quality & Transparency Operational Initiatives Nature & Environmental Partnerships

05 02 ESG AT A GLANCE Key FY2025 Metrics & Highlights 10

GOVERNANCE 26 26 27 28 29 29

ESG Governance & Accountability Ethical Business Practices Data Protection, Cybersecurity & Risk Management Responsible Supply Chain & Procurement Transparency, Metrics & Reporting Looking Ahead: Governance Priorities

BIOSCRIPT SOLUTIONS ESG

INTRODUCTION SECTION 1 Advancing Care with Environmental Responsibility

Page 4

SUSTAINABILITY 2025

INTRODUCTION

RESPONSIBLE CARE FOR PEOPLE AND THE PLANET At BioScript Solutions, care is not confined to clinical settings; it extends to our people, our communities, and the planet we all share.

Building on the foundation established in prior years, this Report reflects our continued progress from defining our ESG priorities to further integrating ESG considerations into decision-making, operations, and culture across our organization.

Healthcare sits at the intersection of human well-being, social equity, and environmental responsibility. BioScript measures the positive impact we create for Canadians and the planet as a key indicator of our success.

This 2025 Environmental, Social and Governance (ESG) Summary Report outlines how we are translating

commitment into action. Building on the foundation established in prior years, this Report reflects a shift from defining our ESG priorities to actively integrating them into decision-making, operations, and culture across our organization.

Our ESG journey is grounded in a simple but powerful belief: doing what’s right for patients, communities, and the planet drives strong health care and business success.

By embedding sustainability, equity, and governance into our operations, we strengthen our ability to support patients, healthcare partners, and Team Members.

LAND ACKNOWLEDGMENT BioScript Solutions respectfully acknowledges that our work takes place on the traditional territories of First Nations, Inuit, and Métis Peoples across what is now known as Canada. These lands have been stewarded by Indigenous Peoples for thousands of years and continue to hold deep cultural, spiritual, and historical significance.

We recognize the enduring impacts of colonization, particularly as they relate to health inequities and access to care. As a healthcare organization, we acknowledge our responsibility to listen, learn, and contribute

to reconciliation through respectful relationships, inclusive practices, and meaningful partnerships.

As we advance our Environmental, Social, and Governance commitments, we also recognize that sustainability and stewardship are not new concepts.

Indigenous ways of knowing and caring for the land offer important lessons that continue to inform our understanding of responsibility to people, communities, and the environment.

Page 5

BIOSCRIPT SOLUTIONS ESG

INTRODUCTION

A MESSAGE FROM OUR CO-FOUNDERS Our vision for BioScript has always been rooted in community. From day one, our purpose has been to provide local care at a national scale, focusing on equitable access for all Canadians. Now, 25 years later, the responsibility we feel towards our communities has only grown, just as we have.

We are measuring our success not only by positive health outcomes for our patients, but by the positive impact we leave for Canadians and the planet we all share.

2025 has been a transformative year in our Environmental, Social and Governance (ESG) journey. We moved from defining our ESG priorities to embedding them into our operational strategy. This shift is already translating into meaningful action across the organization, thanks to the dedication and collaboration from our Team Members.

A key milestone this year was the validation of our greenhouse gas reduction targets by the Science Based Targets Initiative, reinforcing our commitment to credible, science-based decarbonization. We are proud to share this achievement, along with other progress, throughout this report.

Looking ahead in 2026, our focus is clear. We are strengthening long term resilience and accountability, from transitioning toward renewable energy to continuing to mature our processes and governance. At the heart of it all remains community: the communities where our patients and Team Members live, and the communities that will feel the long term impact of the choices we make today. It’s where BioScript began, and it will continue to guide how we grow in the years ahead.

David Ford Co-Founder BioScript Solutions

Page 6

Andrew Steeves Co-Founder BioScript Solutions

SUSTAINABILITY 2025

INTRODUCTION

ABOUT BIOSCRIPT SOLUTIONS National Footprint BioScript Solutions is a national network of 14 pharmacies and over 100 infusion clinics across all 10 provinces. We also operate patient support programs, wholesale distribution centres, and corporate offices, serving communities coast to coast.

Our role extends beyond treatment provider:

We

Our National Footprint allows us to:

1 BioScript Solutions is a leading Canadian healthcare company dedicated to simplifying access to specialty care for patients living with chronic and complex conditions.

Since our founding in 2001, we have worked alongside patients, healthcare providers, manufacturers, payors, and communities to deliver passionate care that is compassionate, reliable, and patient-centered.

What We Do BioScript Solutions operates an integrated network of specialty pharmacy services, infusion clinics, wholesale logistics and distribution, and patient support programs. We provide fast access to complex therapies, helping patients feel confident in their treatment and achieve positive outcomes. Our range of services includes cold-chain logistics, drug reimbursement navigation, disease management support, and infusions and injections. We put patients first in everything we do.

Reach patients in both urban centres and remote communities

2

Align with provincial regulations while maintaining national standards

3

Provide free medication delivery to patients living anywhere in Canada

4

Strengthen resilience and continuity within Canada’s health care system

Our Role in Canada’s Healthcare System BioScript Solutions supports access to specialty therapies that are often complex, time-sensitive, and lifechanging. We help seamlessly connect patients, healthcare providers, manufacturers, and insurers to create a coordinated customer experience and support positive health outcomes.

Provide equitable access to care across diverse and underserved populations.

Reduce barriers to high-quality care through disease education, treatment navigation, and integrated services.

Advance healthcare system efficiency by easing pressure on hospitals and clinics.

Improve adherence and outcomes through personalized patient support.

As demand for specialty care in Canda grows, so does our responsibility to operate ethically and sustainably.

BioScript aims to strengthen our organization and the Canadian healthcare system through strong governance, social responsibility and environmental stewardship.

Page 7

SECTION 2

FY 20 25 A YEAR OF EXECUTION AND INTEGRATION

In this Report, FY2025 refers to our fiscal year of November 1, 2024 – October 31, 2025.

Page 8

In FY2025, BioScript focused on embedding ESG into our everyday operations and moving beyond standalone initiatives to an integrated, enterprise-wide approach.

- Translated emissions data into actionable reduction strategies aligned with climate science - Integrated ESG considerations into procurement, partnerships, and risk management - Strengthened accountability through clear metrics, targets, and reporting - Ensured ESG priorities were reflected across leadership, culture, and decision-making

Page 9

ESG AT A GLANCE K E Y

F Y 2 0 2 5

M E T R I C S

&

H I G H L I G H T S

ENVIRONMENTAL IMPACT Climate Action | Circularity | Nature

ALIGNED SUSTAINABLE DEVELOPMENT GOALS (SDGS): SDG 12 – Responsible Consumption & Production

VALIDATED SCIENCEBASED TARGETS

BioScript Pharmacy Ltd.’s (BioScript Solutions) emissions reduction target was formally validated by the Science-Based Targets initiative (SBTi).

We are committed to reducing our absolute Scope1 and 2 emissions by 42% by 2030 from our 2023 baseline.

2023 baseline emissions:

SDG 13 – Climate Action

SDG 15 – Life on Land

CIRCULAR ECONOMY IN ACTION

224,900 EPS Coolers returned in FY2025

199,000 EPS

+13

from % Increase FY2024

Coolers returned in FY2024

GREENHOUSE GAS INVENTORY Total emissions (FY2024): 13,939 mtCO₂e

2,836

mtCO2e

82%

(11,416.74 mtCO₂e) of emissions occur in Scope 3 (supply chain)

2030 target emissions:

1,191

mtCO2e

6,334 MWh

of electricity tracked across operations

REFORESTATION & BIODIVERSITY

487 Page 10

Trees planted through partnership with Tree Canada

2,343

Trees planted since 2020

ESG AT A GLANCE K E Y

F Y 2 0 2 5

M E T R I C S

&

H I G H L I G H T S

SOCIAL IMPACT Patients | Team Members | Communities

ALIGNED SUSTAINABLE DEVELOPMENT GOALS (SDGS): SDG 3 – Good Health & Well-Being

EXPANDING ACCESS TO SPECIALTY CARE

50,000+ Patients

Served at Coverdale Clinics

160,000+ Patients

Supported by BioScript Pharmacy

1,000,000+ Prescriptions Filled nationwide

103

Coverdale Clinics and

14

BioScript Pharmacies Across Canada

COMMUNITY INVESTMENT

1,600+

SDG 5 – Gender Equality

SDG 10 – Reduced Inequalities

OUR TEAM

401

37

8/10

11,600+

New Team Members Welcomed

Summer Students Hired

Team Member Engagement Score

Peer-to-Peer Recognition Cards Shared

DIVERSITY, INCLUSION, BELONGING & EQUITY (DIBE) BioScript maintains a diverse workforce above Canadian averages.

TEAM MEMBERS Women BioScript Solutions: 48% Canadian Average: 32%

48% 32%

Black, Indigenous, and People of Colour BioScript Solutions: 30% Canadian Average: 22% LEADERSHIP Women BioScript Solutions: 38% Canadian Average: 31% Black, Indigenous, and People of Colour BioScript Solutions: 31% Canadian Average: 6%

30% 6% 22%

31%

31% 38%

Volunteer hours donated

$40,000+

in charitable sponsorships

We continue to sponsor the Indigenous Pharmacy Scholarship, in partnership with the Indigenous Pharmacy Professionals of Canada.

Page 11

ESG AT A GLANCE K E Y

F Y 2 0 2 5

M E T R I C S

&

H I G H L I G H T S

GOVERNANCE & ACCOUNTABILITY Ethics | Oversight | Resilience

ALIGNED SUSTAINABLE DEVELOPMENT GOALS (SDGS): SDG 8 – Decent Work & Economic Growth

STRUCTURED ESG OVERSIGHT We established a cross-functional ESG Committee with visibility and accountability from our Senior Leadership Team.

ETHICAL & RESPONSIBLE WORKFORCE POLICIES - Updated Code of Conduct and Anti-Corruption policies - Formalized Child & Forced Labour Policy

Page 12

SDG 16 – Peace, Justice & Strong Institutions

ALIGNMENT WITH INTERNATIONAL STANDARDS AND BENCHMARKING PLATFORMS: - Science-Based Targets initiative (SBTi) - EcoVadis supplier sustainability assessments - Annual CDP climate disclosure - United Nations Sustainable Development Goals (SDGs)

E

ENVIRONMENT

SECTION 3

Climate Action, Resource Stewardship & Circularity

Page 13

BIOSCRIPT SOLUTIONS ESG

ENVIRONMENT

OUR ENVIRONMENTAL APPROACH BioScript is building a strong foundation for environmental responsibility that strengthens operational excellence and supports long-term resilience.

As BioScript’s environmental programs mature, our focus remains clear:

1

2

3

REDUCE OUR CLIMATE IMPACT

IMPROVE RESOURCE EFFICIENCY

STRENGTHEN CIRCULARITY PRACTICES

Improve energy performance and minimize waste

Expand reuse and recycling initiatives

Measure and reduce greenhouse gas emissions

Did You Know?

Achieving our 2030 target will reduce Scope 1 and 2 emissions by ~1,645 mtCO₂e; equivalent to removing 550 passenger vehicles from the road for one year.

Scope 1 & 2 Emissions Reduction Pathway (2023–2030)

Science-Based Targets FY2025 marked a significant milestone in our climate journey; BioScript Pharmacy Ltd.’s (BioScript Solutions) emissions reduction targets were formally validated by the Science-Based Targets initiative (SBTi).

Our validated near-term target commits us to: -R educe absolute Scope 1 and Scope 2 GHG emissions by 42% by 2030 from a 2023 base year - Measure and reduce Scope 3 emissions

2,836 mtCO₂e

mtCO₂e = Metric Tons of Carbon Dioxide Equivalent

2023 baseline 2024 actual emissions emissions

Page 14

2,522 mtCO₂e

1,191 mtCO₂e 2030 target emissions

SUSTAINABILITY 2025

ENVIRONMENT

CLIMATE ACTION & CARBON MANAGEMENT Emissions Profile & Year-over-Year Tracking Accurately measuring greenhouse gas emissions is essential to understanding our environmental impact and tracking progress toward our climate goals.

In FY2025, we completed our second annual greenhouse gas inventory, covering emissions generated in

The following overview provides a breakFY2024 and building on the baseline established in FY2023. By tracking Scope down of our FY2024 emissions profile, 1, Scope 2, and Scope 3 emissions year including the relative contribution of each over year, we are strengthening our ability scope and the primary activities driving to identify key emission sources, monitor emissions across our value chain. trends, and prioritize the most impactful reduction opportunities.

Did You Know?

Total GHG

FY2023 Emissions

by Scope

FY2024

SCOPE 1

1,384.30 mtCO2e

1,164.56 mtCO2e

SCOPE 2 (market-based)

1,451.52 mtCO2e

1,357.79 mtCO2e

SCOPE 3

12,690.64 mtCO2e

11,416.74 mtCO2e

TOTAL

15,526.46 mtCO2e

13,939.09 mtCO2e

Percentages: GHG Emissions by Scope (FY2024) Scope 1 Scope 2 (market-based)

Scope 3

Temperature-controlled (cold-chain) logistics can generate significantly higher emissions than standard freight due to refrigeration, insulation materials, and expedited transport requirements.

Top Scope 3 Emission Categories (FY2024) Scope 3 Drivers Purchased goods and services and upstream transportation represent our largest Scope 3 categories. These emissions are primarily linked to pharmaceutical sourcing, medical supplies, cold-chain packaging, and temperature-controlled distribution.

6,307.62 mtCQ2e Purchased Goods & Services

425.89 mtCQ2e

2,532.97 mtCQ2e

365.31 mtCQ2e Capital Goods

Upstream Transportation & Distribution

991.49 mtCQ2e

How We Are Driving Emissions Reductions Energy Efficiency Improvements Optimizing energy performance across our facilities, including clinics, pharmacies, and warehouses

Fuel- and Energy-related Activities

161.27 mtCQ2e

Team Member Commute

Waste

623.77 mCQze

8.42 mtCQ2e Upstream Leased Assets

Business Travel

Low-Carbon Electricity Procurement Evaluating renewable electricity solutions aligned with our decarbonization plan

Supplier Engagement Strengthening emissions transparency and environmental performance across our value chain Page 15

BIOSCRIPT SOLUTIONS ESG

ENVIRONMENT

DATA QUALITY & TRANSPARENCY Accurate measurement is the foundation of credible climate action.

BioScript’s greenhouse gas inventories are prepared in accordance with the Greenhouse Gas Protocol Corporate Standard, covering Scope 1, Scope 2, and relevant Scope 3 categories.

We engage an independent carbon accounting partner to support emissions calculations, apply appropriate emissions factors, and validate methodology alignment with recognized standards.

Strengthening Internal Data Governance In FY2025, we: - Formalized recurring data collection processes with our facilities and finance teams - Improved documentation controls to support audit readiness We continue to refine our data collection processes to improve precision as our systems mature and disclosure expectations evolve.

2021 80,581 Page 16

2022 120,000

2023 129,393

Resource Efficiency & Circular Economy Circularity refers to reusing products or resources throughout the value chain to reduce waste — an essential component of responsible healthcare delivery. At BioScript, circularity is embedded into our logistics, distribution, and clinic operations.

Cooler Return Program Established in 2016, our Cooler Return Program encourages patients to return the Expanded Polystyrene (EPS) coolers used in their temperature-sensitive medication deliveries for reuse or recycling.

Every component inside the cooler, including insulation, inserts, and packaging materials, can be returned together to maximize diversion from landfill. Each year, we improve our recovery rates by strengthening reverse logistics and patient awareness.

2024 198,915

2025 224,900

SUSTAINABILITY 2025

ENVIRONMENT

OPERATIONAL INITIATIVES Warehouse Innovation

Clinic Waste Reduction

BioScript is reducing single-use materials across our operations.

Environmental responsibility is embedded at the local level across our 100+ Coverdale Clinics nationwide. Teams actively recycle packaging materials, beverage containers, and cardboard through dedicated recycling systems.

In 2023, a Team Member at our A&D Wholesale warehouse proposed replacing single-use plastic pallet wrap with reusable pallet nets.

These pallet nets have: - Reduced our plastic waste - Lowered associated emissions - Supported more sustainable warehouse operations - Delivered measurable cost savings

NATURE & ENVIRONMENTAL PARTNERSHIPS Tree Canada Partnership BioScript supports reforestation and community greening initiatives across the country through our partnership with Tree Canada. One tree is planted for every new hire, representing our commitment to healthier ecosystems and climate-resilient communities, even as we grow.

Operational improvements include: - Bulk shipment of lab samples, significantly reducing plastic use per blood draw - Increased material segregation to improve recycling rates These actions, while operationally simple, contribute to meaningful waste reduction when implemented across our national footprint.

Number of Trees Planted

FY2025

487

FY2024

388

1 tree = 5 planted

Did You Know?

Since 2020, BioScript has planted 2,343 trees through our partnership with Tree Canada; restoring over 8 acres of forest and supporting biodiversity across Canada.

LOOKING AHEAD ENVIRONMENTAL PRIORITIES

In FY2026, BioScript will focus on transitioning toward renewable energy. This is one of the most impactful levers available to reduce our operational carbon footprint while supporting Canada’s broader energy transition.

FY2026 Environmental Priorities

Accelerate

Advance

Search

Strengthen

Accelerate measurable emissions reductions

Advance structured decarbonization planning

Search for renewable energy opportunities

Strengthen data visibility to support performance tracking and accountability Page 17

S

SOCIAL SECTION 4 Patients, People, Communities & Culture

Page 18

SUSTAINABILITY 2025

SOCIAL

PATIENT IMPACT At BioScript Solutions, every clinic, pharmacy, and patient support interaction is designed to remove barriers, reduce complexity, and ensure that Canadians living with chronic and rare conditions receive timely, coordinated care.

With a growing national network of over 100 clinics and 14 pharmacies, we continue to strengthen our ability to serve patients in both urban centers and remote communities.

In FY2025, we welcomed 401 new Team Members and 37 students, strengthening clinical capacity and building the next generation of healthcare professionals. Today, our organization is powered by over 1600 Team Members nationwide.

This growth represents thousands of individuals gaining improved continuity of care, therapy adherence, and clinical oversight.

Did You Know?

Our most northern Coverdale Clinic is located in Fort McMurray, Alberta, 450 km north of Edmonton.

Ethical and Equitable Access to Care Our mission is to simplify access to specialty care, and access must also be equitable. We work closely with healthcare providers, manufacturers, payers, and patient advocacy groups to help navigate reimbursement processes, financial assistance programs, and therapy education.

Our patient support programs help ensure that cost, geography, or system complexity does not prevent patients from receiving life-changing therapies. Through this integrated approach, we are advancing equitable healthcare delivery while maintaining the highest standards of safety, quality assurance, and regulatory compliance.

National Reach & Patients Served

50,000+

160,000+

1000,000+

55,000

Patients received care at Coverdale Clinics

Patients supported by BioScript Pharmacy

Prescriptions were filled by BioScript Pharmacy

Patients were enrolled in NavieGo patient support programs

Page 19

OUR TEAM MEMBERS AND WELL BEING Health & Safety

Health & Wellness Coverage

A healthy team is foundational to delivering high-quality patient care.

Across our national network, our Joint Health and Safety Committees continue to monitor workplace conditions, mitigate risks, and promote proactive safety culture.

- Comprehensive health, dental, and vision insurance - Expanded mental health coverage with access to virtual and in-person support - Employee and Family Assistance Program (EFAP) offering confidential counseling, eldercare, childcare, addiction support, and financial planning resources - Participation in the Not Myself Today program in partnership with the Canadian Mental Health Association - Free Wellbeats membership with access to 1,200+ virtual fitness, nutrition, and mindfulness classes

Comprehensive Team Member Benefits Our benefits framework is designed to support physical health, mental wellness, financial security, and life transitions, reflecting the diverse needs of our national team.

Page 20

- Customizable Personal Wellness accounts to support individualized health priorities - Coverage for specialized health needs including prosthetics, diabetic care, hearing and visual aids, and weight loss support - Gender transition support and inclusive coverage for fertility, adoption, and surrogacy - Ergonomic equipment support

Inclusive & Flexible Leave Policies

Mental Health & Well-Being Initiatives - Wellbeats challenges – employee engagement contests focused on mindfulness at work, driving strong participation across locations - Wellness Lunch & Learns – quarterly, virtual sessions led by external guest speakers to strengthen resilience and connection Financial Security - Employer-matched Group RRSP program - Tax-Free Savings Account (TFSA) options - Competitive compensation enhancements including bilingual premiums, northern allowances, signing bonuses, and performance-based incentives - Team Member prescription discounts and corporate discount programs

“Our team supports causes that matter to them personally. When people care deeply about something, that is where real impact happens.

By backing the charities our people choose, we are investing in the communities that matter to them and to us.”

- Flexible Paid Time Off (vacation, personal, and sick leave) - Volunteer Time Off (one paid day annually) - Parental, adoption and surrogacy leave - Bereavement and wedding leave - Religious accommodation and flexible scheduling where appropriate Our approach to benefits is intentionally inclusive and adaptable, ensuring that Team Members feel supported at every stage of their personal and professional journeys.

Page 21

BIOSCRIPT SOLUTIONS ESG

SOCIAL

INDIGENOUS RECONCILIATION & EQUITY IN HEALTHCARE

DIVERSITY, INCLUSION, BELONGING & EQUITY (DIBE)

Healthcare equity requires representation.

Governance & Structure

BioScript continues to sponsor the Indigenous Pharmacy Scholarship, supporting Indigenous students pursuing careers in pharmacy. The scholarship is in partnership with the Indigenous Pharmacy Professionals of Canada (IPPC) and the Canadian Pharmacists Association (CPhA).

Our DIBE Committee continues to operate as a cross-functional, nationally represented working group dedicated to embedding inclusion into our policies, programming, and workplace culture. With defined governance, executive visibility, and allocated budget support, the committee ensures accountability and sustained progress.

We are committed to creating pathways that support Indigenous leadership within the healthcare system and address system inequities.

Training, Education & Inclusive Practices

Indigenous Pharmacy Scholarship Recipients (2024/2025):

Kevin Magun PharmD Scholarship Recipient University of British Columbia

Nicole Beskorwayne Pharmacy Technician Scholarship Recipient, Saskatchewan Polytechnic

Page 22

All new Team Members complete DIBE training during onboarding, with ongoing learning opportunities available throughout the year.

As a proud partner of the Canadian Centre for Diversity and Inclusion (CCDI), we provide access to national research, educational webinars, benchmarking tools, and best practices that strengthen our inclusion framework.

SUSTAINABILITY 2025

SOCIAL

ENGAGEMENT, LISTENING & CULTURE

LEARNING, DEVELOPMENT & TALENT RETENTION

We leverage Officevibe, a real-time Team Member engagement platform, to continuously measure and strengthen workplace culture. Through monthly pulse surveys, Team Members provide anonymous feedback on key indicators including leadership, communication, recognition, well-being, alignment, and professional growth.

Professional Development We invest in our Team Members so they can continue delivering exceptional patient care. Financial support for continuing education, professional memberships, and certifications ensures our teams remain clinically and professionally advanced.

Key Engagement Insights from 2025:

Leadership & Skills Training

63%

8/10

Average participation in monthly engagement surveys

Score achieved for overall engagement

11,600

43

Recognition cards shared amongst Team Members

Employee Net Promoter Score. 27% higher than other organizations in our industry

BioScript is strengthening leadership capabilities across all levels through structured development pathways. Our annual Leadership Summit brings together more than 150 leaders from across Canada to foster crossfunctional collaboration and strengthen people leadership skills. In addition, BioScript leaders have access to internal learning programs, webinars, and a dedicated online space to support ongoing communication and development.

Innovation & Career Growth BioScript creates a safe environment for Team Members to speak up, contribute ideas, and grow professionally through dedicated pathways that connect innovation directly with Senior Leadership. Monthly peer-nominated awards further recognize Team Members who exemplify our Core Values, including Putting Patients First, Accountability, and Innovation.

This culture of recognition and open dialogue supports Team Member retention and longterm career progression.

Page 23

BIOSCRIPT SOLUTIONS ESG

SOCIAL

COMMUNITY ENGAGEMENT & SOCIAL IMPACT

G

Volunteer Time Off

Local & National Healthcare Initiatives

BioScript’s Volunteer Time Off program offers each BioScript Team Member a paid day off so they can give back to their communities. In 2025, BioScript Team Members dedicated over 1,600 volunteer hours — equivalent to over 215 working days — to causes across Canada and beyond, from beach cleanups to health and food security initiatives.

We are proud to foster a culture of compassion, social responsibility, and meaningful contribution.

We proudly support national patient advocacy organizations and community-based healthcare initiatives that improve patient education, access, and outcomes across Canada. These partnerships extend our impact beyond our walls and strengthen the Canadian healthcare ecosystem.

Here’s a glimpse into how some of our Team Members used their time to make a difference:

- Over $25,000 in corporate sponsorships, supporting MS Walk, Gutsy Walk, and Moncton’s New Year’s Eve Family Fun Fest.

Dragon Boat Festival

- Over $10,000 in discretionary sponsorships, including Light the Night, Lady Ball, Asthma Canada, River of Pride, and local sports teams.

Our Team Members participated in the 2025 Greater Moncton Dragon Boat Festival, which is a long-standing tradition at BioScript. Our two participating teams, Blazing BioScripters and Paddling BioScripters, raised over $5,000 for the Lions Sick Children’s Fund.

LOOKING AGEAD: SOCIAL PRIORITIES Team Members & Culture

DIBE Commitments

Community Investment

Continue to enhance mental health support, leadership development, and engagement strategies to sustain a resilient, high-performing team.

Release our 2026 DIBE survey, strengthen representation pathways, and embed inclusion into recruitment, promotion, and supplier practices.

Deepen partnerships aligned with patient access, healthcare equity, and underserved communities to ensure our social investments drive meaningful, long-term outcomes.

Page 24

G

GOVERNANCE SECTION 5 Ethics, Accountability & Responsible Business

ETHICS, ACCOUNTABILITY & RESPONSIBLE BUSINESS Strong governance underpins everything we do at BioScript Solutions, from safeguarding patient data to ensuring ethical business practices across our value chain. As a healthcare organization, trust, accountability, and transparency are foundational to delivering care responsibly and sustainably.

ESG Governance & Accountability Established in FY2024, BioScript’s ESG Committee serves as the central body guiding sustainability strategy and implementation across the organization. The committee is composed of cross-functional Team Members representing operations, vendor management, sustainability, compliance, human resources, strategy, and legal.

The ESG Committee is overseen by BioScript’s Senior Leadership Team, including CEO Lisa Matar. This governance structure enables timely decision making and ensures that sustainability and ESG considerations are embedded within BioScript’s strategic framework and operational decisionmaking, rather than treated as standalone initiatives.

Ethical Business Practices BioScript Solutions conducts business with integrity, transparency, and accountability. We maintain the trust of our patients, partners, Team Members, and the communities we serve.

Our policies and governance framework are designed to uphold the highest legal, regulatory, and professional standards across all aspects of our operations.

The ESG Committee is responsible for: Reviewing progress against environmental, social, and governance objectives

Page 26

Monitoring data collection and reporting timelines

Identifying risks and emerging regulatory considerations

Driving continuous improvement initiatives

SUSTAINABILITY 2025

GOVERNANCE

Code of Conduct

Did You Know?

Our Code of Conduct, Conflict of Interest, and Anti-Corruption Policy establishes clear expectations for ethical behavior across the organization. All Team Members are required to:

Specialty medications are often time-sensitive and temperaturecontrolled; making operational resilience critical to treatment success for patients.

- Act with honesty, fairness, and professionalism - Avoid and disclose conflicts of interest - Comply with all applicable laws, regulations, and industry standards - Protect confidential information and company assets - Uphold our values of transparency and accountability Human Rights Commitments In FY2025, we formalized a Child and Forced Labour Policy. This policy reinforces our zero-tolerance stance on child labour, forced labour, and human trafficking within our operations and suppliers. It outlines expectations for ethical labour practices, supplier compliance, and responsible sourcing in alignment with evolving regulatory requirements and stakeholder expectations.

We are committed to ensuring that our business activities (and those of our partners) respect human dignity and internationally recognized labour standards.

DATA PROTECTION, CYBERSECURITY & RISK MANAGEMENT As a national healthcare organization, BioScript Solutions manages sensitive patient, clinical, and Team Member information. Protecting this data is central to our governance framework. We invest in highquality data protection and cybersecurity and maintain enterprise risk management and business continuity plans to safeguard our patients, Team Members, and partners.

Protecting Patient and Team Member Data Protecting patient trust and safeguarding sensitive information are core responsibilities at BioScript. We adhere to all applicable privacy and healthcare regulatory requirements and apply strong data protection standards across our operations.

Our oversight practices support the responsible use of patient, clinical, and Team Member information throughout its full lifecycle, including secure storage, appropriate retention, and safe disposal.

Data protection is embedded into our dayto-day operations through role-based access controls, ongoing privacy and compliance training for Team Members, and clear accountability across teams, systems, and third-party partners. We regularly review and update our policies and procedures to ensure continued alignment with evolving regulatory expectations.

business operations. Our practices include continuous network monitoring, threat detection protocols, routine system updates, and proactive vulnerability mitigation. Team Members complete ongoing awareness training focused on phishing, cyber threats, and secure data practices, reinforcing a strong security culture across the organization.

Business Continuity and Resilience Planning Delivering uninterrupted specialty care is critical to helping patients achieve positive treatment outcomes.

We maintain business continuity and resilience plans designed to support: - Operational continuity during disruptions - Emergency response coordination across clinics, pharmacies, and corporate offices - Ongoing risk mapping and mitigation planning

Cybersecurity Governance BioScript has a dedicated IT Security team to protect our organization against unauthorized access, data breaches, and system disruption. The Security team is represented within our IT leadership team to ensure cybersecurity is understood and addressed at the leadership level.

We take a risk-based approach to cybersecurity, prioritizing protections for systems that support patient care and core Page 27

BIOSCRIPT SOLUTIONS ESG

GOVERNANCE

IT Equipment Donations

Suppliers are assessed, as applicable, based on:

Where feasible and appropriate, decommissioned IT equipment is donated to community organizations to extend its useful life and reduce electronic waste. This initiative supports digital access within communities while contributing to waste reduction and circular economy principles.

- Compliance with BioScript’s internal quality and regulatory requirements - Past business performance and perceived reliability - Financial and operational history - Data privacy and cybersecurity controls - Health, safety, and environmental performance - Commitment to sustainability practices - Supplier diversity status - Service offerings and value - Any other factor deemed relevant to the assessment

RESPONSIBLE SUPPLY CHAIN & PROCUREMENT As a healthcare organization, BioScript Solutions recognizes that our responsibility extends beyond our own operations. Our supply chain plays a critical role in delivering safe, ethical, and sustainable care, and we work closely with suppliers to uphold shared expectations for high quality standards, regulatory compliance and responsible business practices.

Supplier Diversity Integration – Supplier Assessment Components In FY2025, BioScript formalized its Supplier Assessment Components Guide. The Guide strengthens our procurement governance by defining structured criteria to evaluate suppliers and embedding ESG considerations directly into procurement decision-making.

Supplier Diversity Consideration Where suppliers are otherwise evaluated as equivalent across BioScript’s required criteria (e.g., quality, cost, performance, compliance, and value), we will give preference to engaging diverse suppliers, whether certified or self-identified, in alignment with our Diversity, Inclusion, Belonging and Equity Policy.

BioScript will establish a diverse supplier expenditure baseline and use the data collected through our Supplier Management Program to define practical yet meaningful objectives to enhance engagement with diverse suppliers.

By embedding supplier diversity into our formal assessment framework, we are advancing equity while maintaining the highest standards of quality, compliance, and patient safety.

Our reporting is aligned with and disclosed to recognized international standards and external frameworks, including:

Page 28

EcoVadis

CDP

- Complete an annual sustainability assessment across Environment, Labor & Human Rights, Ethics, and Sustainable Procurement.

- Provide an annual climate disclosure to strengthen transparency and benchmark environmental performance.

Science Based Targets initiative (SBTi)

United Nations Sustainable Development Goals (SDGs)

- Align our emissions reduction targets with climate science and the 1.5°C pathway.

- Align environmental, healthcare access, and governance initiatives with global development priorities.

SUSTAINABILITY 2025

GOVERNANCE

TRANSPARENCY, METRICS & REPORTING

LOOKING AHEAD – GOVERNANCE PRIORITIES

Reporting Boundaries This ESG Summary Report covers BioScript Solutions’ operations across Canada for FY2025 (November 1, 2024 – October 31, 2025), unless otherwise stated.

As the Canadian healthcare system continues to evolve, expectations around transparency, climate action, and social equity are also rising. BioScript is taking deliberate action by prioritizing responsible governance and sustainability across our operations and decision-making, in the way we support patients, partners, Team Members, and the communities we serve.

Transparency is essential to building trust and accountability in healthcare. BioScript reports on ESG performance to provide clear, consistent insight into our impacts, progress, and areas for continued improvement.

We track key ESG metrics to inform decision-making, measure progress over time, and ensure data integrity, regulatory alignment, and accountability.

As our ESG initiatives continue to mature, we will continue strengthening data quality, governance processes, and disclosure practices in line with evolving expectations.

Strong governance enables BioScript to advance environmental and social priorities with clarity, accountability, and confidence as our ESG program continues to evolve.

In FY2025, we further formalized our governance structures, advanced our decarbonization journey, strengthened supplier accountability across our value chain, and deepened our commitment to diversity, inclusion, belonging, and equity. We are proud of the progress achieved to date and remain motivated by the work ahead.

In FY2026, our focus will shift toward strengthening controls, formalizing processes, and enhancing oversight mechanisms to support longterm resilience and accountability across our ESG priorities.

As our organization grows in scale and complexity, we remain committed to evolving alongside regulatory requirements and stakeholder expectations. We continue embedding ESG principles across our nationwide specialty care model to support sustainable, responsible healthcare delivery over the long term.

ESG is embedded in how we operate today, and how we plan for the future.

Page 29

Prepared by:

Reviewed by:

Harnaaz Sandhu

Nellie Rousselle

Environmental & Business Sustainability Coordinator

Organizational Development and Engagement Lead Jonathan Lutes General Counsel

Marc Grenier Vice President of Operations Lisa Matar, Chief Executive Officer